Karyopharm Therapeutics' blood cancer drug meets one of two main goals in study-March 2024-www.financetom.com

Karyopharm Therapeutics' blood cancer drug meets one of two main goals in study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Karyopharm Therapeutics' blood cancer drug meets one of two main goals in study

Mar 24, 2026 4:29 AM

March 24 (Reuters) - Karyopharm Therapeutics ( KPTI )

said on Tuesday its oncology therapy showed a statistically

significant improvement in spleen volume in a late-stage trial

in patients with a rare blood cancer, one of the study's main

goals.

However, the drug missed the other goal of showing an

improvement in patients' symptoms.

Previous page： UniQure Says Aligned With FDA on Approval Pathway for Huntington's Disease Drug; Shares Jump Next page： Cardiff Oncology Prices Oversubscribed $40 Million Stock Offering

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

UniQure Says Aligned With FDA on Approval Pathway for Huntington's Disease Drug; Shares Jump

Dec 10, 2024

07:56 AM EST, 12/10/2024 (MT Newswires) -- UniQure ( QURE ) shares climbed by more than 70% in premarket trading after saying it has reached agreement with the US Food and Drug Administration on elements of an Accelerated Approval pathway for its drug AMT-130, a potential Huntington's disease treatment. The company said the FDA accepted data from ongoing phase 1/2...

Cardiff Oncology Prices Oversubscribed $40 Million Stock Offering

Dec 10, 2024

07:51 AM EST, 12/10/2024 (MT Newswires) -- Cardiff Oncology ( CRDF ) said Tuesday its oversubscribed public offering of nearly 15.4 million common shares has been priced at $2.60 apiece. The offering, which will likely close on or about Wednesday, is expected to generate roughly $40 million in gross proceeds that will be used for working capital and other general...

Prime Mining Provides Drill Results From Los Reyes Project in Mexico

Dec 10, 2024

07:52 AM EST, 12/10/2024 (MT Newswires) -- Prime Mining ( PRMNF ) reported Tuesday expansion drilling results from its Los Reyes project in Mexico. Highlights from the Guadalupe East area include 42.07 grams per tonne (g/t) gold equivalent over 1.0 meter and 5.32 g/t gold equivalent over 2.4 meters. Guadalupe East continues to provide exceptional high-grade results, CEO Scott Hick...

Lindblad Expeditions Holdings Appoints Natalya Leahy as CEO, Rick Goldberg as CFO

Dec 10, 2024

07:55 AM EST, 12/10/2024 (MT Newswires) -- Lindblad Expeditions Holdings ( LIND ) said Tuesday that Natalya Leahy will succeed Sven-Olof Lindblad as chief executive officer, effective Jan. 1. The company also said Rick Goldberg will succeed L. Dyson Dryden as chief financial officer, effective Dec. 31. Before the appointment, Leahy was president of Seabourn, while Goldberg was CFO of...